What is Mouse Specifics?
Mouse Specifics specializes in developing advanced instruments for laboratory animal research, aiming to enhance the quality and translatability of pre-clinical study data. Their product suite includes DigiGait for comprehensive gait analysis and ECGenie for non-invasive electrocardiogram recording. These tools are designed to empower researchers in understanding human diseases more efficiently and cost-effectively, while also prioritizing lab animal welfare. The company's focus on improving health monitoring and disease understanding through animal models positions it as a key player in the pre-clinical research sector.
How much funding has Mouse Specifics raised?
Mouse Specifics has raised a total of $51K across 1 funding round:
Debt
$51K
Debt (2021): $51K with participation from PPP
Key Investors in Mouse Specifics
PPP
Public-Private Partnership
What's next for Mouse Specifics?
With substantial expansion capital secured at a significant Series B/C stage, Mouse Specifics is poised for accelerated growth and further innovation. The recent investment is expected to fuel the scaling of operations, enhance product development, and broaden market reach. This strategic financing will likely enable the company to deepen its impact on pre-clinical studies, supporting researchers in generating higher quality, translatable data for a more profound understanding of human diseases. Future developments may include expanding their instrument portfolio or forging new research partnerships.
See full Mouse Specifics company page
